EA199900153A1 - СПОСОБ ПОЛУЧЕНИЯ ДРОСПИРЕНОНА (6β, 7β; 15β, 16β-ДИМЕТИЛЕН-3-ОКСО-17α-ПРЕГН-4-ЕН-21,17-КАРБОЛАКТОНА, DRSP) И 6β,7β;15β,16β-ДИМЕТИЛЕН-5β-ГИДРОКСИ-3-ОКСО-17α-АНДРОСТАН-21,17-КАРБОЛАКТОН (ZK 90965) В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА - Google Patents

СПОСОБ ПОЛУЧЕНИЯ ДРОСПИРЕНОНА (6β, 7β; 15β, 16β-ДИМЕТИЛЕН-3-ОКСО-17α-ПРЕГН-4-ЕН-21,17-КАРБОЛАКТОНА, DRSP) И 6β,7β;15β,16β-ДИМЕТИЛЕН-5β-ГИДРОКСИ-3-ОКСО-17α-АНДРОСТАН-21,17-КАРБОЛАКТОН (ZK 90965) В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА

Info

Publication number
EA199900153A1
EA199900153A1 EA199900153A EA199900153A EA199900153A1 EA 199900153 A1 EA199900153 A1 EA 199900153A1 EA 199900153 A EA199900153 A EA 199900153A EA 199900153 A EA199900153 A EA 199900153A EA 199900153 A1 EA199900153 A1 EA 199900153A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydroxy
dimethylene
oxo
dimetylene
carbolacton
Prior art date
Application number
EA199900153A
Other languages
English (en)
Other versions
EA001947B1 (ru
Inventor
Йорг-Торштен Мор
Клаус Никкиш
Original Assignee
Шеринг Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7803224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199900153(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Шеринг Акциенгезельшафт filed Critical Шеринг Акциенгезельшафт
Publication of EA199900153A1 publication Critical patent/EA199900153A1/ru
Publication of EA001947B1 publication Critical patent/EA001947B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

В заявке описывается получение дроспиренона (6β,7β;15β,16β-диметилен-3-оксо-17α-прегн-4-ен-21,17-карболактона,) (I)а также 7α-(3-гидрокси-1-пропил)-6β,7β;15β,16β-диметилен-5β-андростан-3β,5,17β-триола (ZK 92836) и 6β,7β;15β,16β-диметилен-5β-гидрокси-3-оксо-17α-андростан-21,17-карболактона () в качестве промежуточных продуктов.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900153A 1996-08-12 1997-08-11 СПОСОБ ПОЛУЧЕНИЯ ДРОСПИРЕНОНА (6b,7b;15b,16b-ДИМЕТИЛЕН-3-ОКСО-17a-ПРЕГН-4-ЕН-21,17-КАРБОЛАКТОНА, DRSP) И 6b,7b;15b,16b-ДИМЕТИЛЕН-5b-ГИДРОКСИ-3-ОКСО-17a-АНДРОСТАН-21,17-КАРБОЛАКТОН (ZK 90965) В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА EA001947B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19633685A DE19633685C1 (de) 1996-08-12 1996-08-12 Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
PCT/EP1997/004342 WO1998006738A1 (de) 1996-08-12 1997-08-11 Verfahren zur herstellung von drospirenon und zwischenprodukten davon

Publications (2)

Publication Number Publication Date
EA199900153A1 true EA199900153A1 (ru) 1999-06-24
EA001947B1 EA001947B1 (ru) 2001-10-22

Family

ID=7803224

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900153A EA001947B1 (ru) 1996-08-12 1997-08-11 СПОСОБ ПОЛУЧЕНИЯ ДРОСПИРЕНОНА (6b,7b;15b,16b-ДИМЕТИЛЕН-3-ОКСО-17a-ПРЕГН-4-ЕН-21,17-КАРБОЛАКТОНА, DRSP) И 6b,7b;15b,16b-ДИМЕТИЛЕН-5b-ГИДРОКСИ-3-ОКСО-17a-АНДРОСТАН-21,17-КАРБОЛАКТОН (ZK 90965) В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА

Country Status (27)

Country Link
US (2) US6121465A (ru)
EP (4) EP2168974B1 (ru)
JP (1) JP3333524B2 (ru)
KR (1) KR100473297B1 (ru)
CN (1) CN1158300C (ru)
AT (3) ATE215557T1 (ru)
AU (1) AU729149B2 (ru)
BG (1) BG62776B1 (ru)
BR (1) BR9711060A (ru)
CA (1) CA2261137C (ru)
CZ (1) CZ297255B6 (ru)
DE (4) DE19633685C1 (ru)
DK (4) DK1149841T3 (ru)
EA (1) EA001947B1 (ru)
ES (4) ES2320626T5 (ru)
HK (1) HK1021190A1 (ru)
HU (1) HU223106B1 (ru)
IL (1) IL127963A (ru)
IS (1) IS2100B (ru)
NZ (1) NZ333697A (ru)
PL (1) PL187474B1 (ru)
PT (4) PT1149840E (ru)
SI (3) SI1149841T1 (ru)
SK (1) SK283546B6 (ru)
TR (1) TR199900262T2 (ru)
UA (1) UA55423C2 (ru)
WO (1) WO1998006738A1 (ru)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
DK1380301T3 (da) 1999-08-31 2009-04-20 Bayer Schering Pharma Ag Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
DE60113809T2 (de) * 2000-01-18 2006-06-22 Schering Ag Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie
JP2004521951A (ja) 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
MEP35908A (en) 2002-04-26 2011-02-10 Bayer Schering Pharma Ag Treatment of hypertension in women receiving hormone replacement therapy
US7786101B2 (en) 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
CL2004000574A1 (es) * 2003-03-21 2005-02-11 Pharmacia Corp Sa Organizada B Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion.
ITMI20040367A1 (it) 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
HUP0402465A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
DE102004058300B4 (de) * 2004-12-02 2016-09-15 Austriamicrosystems Ag Schaltungsanordnung zur Erzeugung eines komplexen Signals und Verwendung in einem Hochfrequenz-Sender oder -Empfänger
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
US7319154B2 (en) 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
PT1910403T (pt) 2005-07-21 2016-07-14 Bayer Pharma AG Processo para a produção de 3-oxo-pregn-4-eno-21,17- carbolactonas através da oxidação isenta de metais de 17- (3-hidroxipropil)-3,17-diidroxiandrostanos
PL1746101T5 (pl) * 2005-07-21 2014-11-28 Bayer Pharma AG Sposób wytwarzania 3-oksopreg-4-eno-21,17-karbolaktonów drogą bezmetalowego utleniania 17-(3-hydroksypropylo-3,17-dihydroksyandrostanu
US20070255380A1 (en) 2006-04-27 2007-11-01 Peter Meyer Electrode pad packaging systems and methods
EP1902711A1 (en) * 2006-09-20 2008-03-26 KAIROSmed GmbH Oral modified release formulations containing Drospirenon and 8-Prenylnaringenin for use in Hormone Replacement Therapy (HRT)
EP2057182A2 (en) * 2007-05-01 2009-05-13 Sicor, Inc. A process for preparing drospirenone and intermediate thereof
DE102007030596B3 (de) * 2007-06-28 2009-03-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung von 17-(3-Hydroxypropyl)-17-hydroxysteroiden
EP2265629B1 (en) * 2008-03-05 2015-06-24 Evestra, Inc. Bismethylene-17 carbolactones and related uses
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
WO2010094623A1 (en) 2009-02-18 2010-08-26 Bayer Schering Pharma Aktiengesellschaft Formulation comprising drospirenone for subcutaneous or intramuscular administration
WO2010094624A1 (en) 2009-02-18 2010-08-26 Bayer Schering Pharma Aktiengesellschaft Particles comprising drospirenone encapsulated in a polymer
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
ES2432063T3 (es) * 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
DE102009031909B4 (de) 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus Prasteron
EP2548881B1 (en) * 2010-03-16 2014-12-17 Taizhou Taifa Pharmaceuticals Co., Ltd Preparation method of drospirenone
CN101830959B (zh) * 2010-05-27 2012-07-18 杭州龙山化工有限公司 一种曲螺酮的合成方法
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
ES2419663T3 (es) 2010-08-03 2013-08-21 Newchem S.P.A. Métodos para la preparación de Drospirenona y productos intermedios de la misma
WO2012107513A1 (en) 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
ITMI20111383A1 (it) 2011-07-25 2013-01-26 Ind Chimica Srl Processo per la preparazione di drospirenone
CA2854215A1 (en) * 2011-11-04 2013-05-10 Bayer Pharma Aktiengesellschaft 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17.beta.-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
ES2607778T3 (es) 2011-11-22 2017-04-04 Industriale Chimica S.R.L. Proceso para la preparación de drospirenona
EP2597101A1 (en) 2011-11-22 2013-05-29 Industriale Chimica S.R.L. Process for the preparation of drospirenone
ES2651145T3 (es) 2013-02-20 2018-01-24 Industriale Chimica S.R.L. Proceso para la preparación de drospirenona
PL2984100T3 (pl) * 2013-04-12 2017-10-31 Ind Chimica Srl Sposób otrzymywania drospirenonu
AU2016282863B2 (en) 2015-06-23 2021-05-27 Laboratorios Leon Farma Sa Drospirenone-based contraceptive for a female patient affected with excess weight
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
CN113387993A (zh) * 2021-07-06 2021-09-14 江西百思康瑞药业有限公司 一种屈螺酮的合成方法
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception
WO2023152658A1 (en) 2022-02-10 2023-08-17 Lupin Limited Slow release drospirenone tablet composition
WO2023165988A1 (en) 2022-03-01 2023-09-07 Chemo Research, S.L. Chewable oral contraceptive

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
DE3265852D1 (en) * 1981-09-21 1985-10-03 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE3414508A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrfach tritiierte steroid-20.17-spirolactone und ihre verwendung als tracersubstanzen
DE3626838A1 (de) * 1986-08-08 1988-02-11 Schering Ag Verfahren zur herstellung von 17(alpha)-pregnan-21,17-carbolactonen
US5106995A (en) * 1989-05-05 1992-04-21 Isp Investments Inc. Production of lactones from diols
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens

Also Published As

Publication number Publication date
KR100473297B1 (ko) 2005-03-07
TR199900262T2 (xx) 1999-03-22
DK1149840T4 (da) 2013-07-01
SI0918791T1 (en) 2002-12-31
DK1149840T5 (da) 2013-09-30
ES2438941T1 (es) 2014-01-20
EP1149841B1 (de) 2009-10-28
AU729149B2 (en) 2001-01-25
CA2261137C (en) 2005-03-15
NZ333697A (en) 2000-08-25
US6121465A (en) 2000-09-19
IS4965A (is) 1999-01-29
ES2175451T7 (es) 2012-11-19
CZ297255B6 (cs) 2006-10-11
CZ47099A3 (cs) 1999-05-12
ES2175451T3 (es) 2002-11-16
PT2168974E (pt) 2014-08-26
PT1149841E (pt) 2010-01-29
DE19633685C1 (de) 1997-10-09
JP2000516226A (ja) 2000-12-05
EA001947B1 (ru) 2001-10-22
EP1149840A2 (de) 2001-10-31
WO1998006738A1 (de) 1998-02-19
IL127963A (en) 2004-06-20
IS2100B (is) 2006-04-12
AU4014497A (en) 1998-03-06
ATE420098T1 (de) 2009-01-15
US6933395B1 (en) 2005-08-23
EP1149840B2 (de) 2013-05-15
DE59713018D1 (de) 2009-12-10
BG62776B1 (bg) 2000-07-31
EP0918791A1 (de) 1999-06-02
HU223106B1 (hu) 2004-03-29
HUP9903089A3 (en) 2001-07-30
DK1149840T3 (da) 2009-04-27
JP3333524B2 (ja) 2002-10-15
ATE446966T1 (de) 2009-11-15
EP0918791B3 (de) 2012-01-18
BG102976A (en) 1999-08-31
EP0918791B1 (de) 2002-04-03
PL187474B1 (pl) 2004-07-30
DK2168974T3 (da) 2014-08-11
PT1149840E (pt) 2009-03-31
EP2168974A3 (de) 2013-03-06
EP1149841A2 (de) 2001-10-31
SK19499A3 (en) 1999-10-08
CN1158300C (zh) 2004-07-21
ES2438941T3 (es) 2014-07-21
EP0918791B8 (de) 2003-01-08
EP1149841A3 (de) 2004-12-01
ES2320626T3 (es) 2009-05-27
BR9711060A (pt) 1999-08-17
EP1149840B1 (de) 2009-01-07
ES2320626T5 (es) 2013-09-05
EP1149840A3 (de) 2004-12-01
SI1149841T1 (sl) 2010-02-26
CA2261137A1 (en) 1998-02-19
SI1149840T2 (sl) 2013-08-30
DE59706887D1 (de) 2002-05-08
IL127963A0 (en) 1999-11-30
SI1149840T1 (sl) 2009-06-30
CN1223662A (zh) 1999-07-21
ES2335860T3 (es) 2010-04-06
PL331530A1 (en) 1999-07-19
ATE215557T1 (de) 2002-04-15
DK1149841T3 (da) 2010-03-08
KR20000029939A (ko) 2000-05-25
HK1021190A1 (en) 2000-06-02
DK0918791T3 (da) 2002-07-15
EP2168974B1 (de) 2014-07-02
PT918791E (pt) 2002-09-30
DE59712991D1 (de) 2009-02-26
UA55423C2 (ru) 2003-04-15
EP2168974A2 (de) 2010-03-31
SK283546B6 (sk) 2003-09-11

Similar Documents

Publication Publication Date Title
EA199900153A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ДРОСПИРЕНОНА (6β, 7β; 15β, 16β-ДИМЕТИЛЕН-3-ОКСО-17α-ПРЕГН-4-ЕН-21,17-КАРБОЛАКТОНА, DRSP) И 6β,7β;15β,16β-ДИМЕТИЛЕН-5β-ГИДРОКСИ-3-ОКСО-17α-АНДРОСТАН-21,17-КАРБОЛАКТОН (ZK 90965) В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА
EP2108652A3 (en) Process for the preparation of drospirenone
AU3061997A (en) A continuous, high-speed method for producing a pant-style garment having a pair of elasticized leg openings
EP2433951A3 (en) A process for the preparation of drospirenone
EA200000381A1 (ru) Препарат 2-метил-тиено-бензодиазепина
DE59607461D1 (de) Künstliche hüftgelenkpfanne
TR200002774T2 (tr) Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri
DE69518077D1 (de) Schneidgerät für die femorale interkondyläre nut einer von hinten stabilisierten knieprothese
AU4993297A (en) Reinforced glove and method and apparatus for forming the same
FR2702150B1 (fr) Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA.
MXPA02002043A (es) Composicion farmaceutica de etinilestradiol y drospirenona para el uso como anticonceptivo.
ES2023774A6 (es) Procedimiento para la preparacion del intermedio de diltiazem.
ES1031942U (es) Perno de anclaje perfeccionado de expansion multiple radial.
RU2183103C2 (ru) Способ лечения врожденной варусной деформации шейки бедренной кости
EA200100745A1 (ru) СПОСОБ ПОЛУЧЕНИЯ 6β,7β;15β,16β- ДИМЕТИЛЕН-5β-ГИДРОКСИ-3-ОКСО-17α-АНДРОСТАН-21,17-КАРБАЛАКТОНА
BR9809436A (pt) Derivados estrogênicos de 19-noradnrost-17-ona com um anel aromático b
PT1294739E (pt) Compostos esteroides 16, 17-carbociclicos condensados possuindo actividade estrogenica selectiva
BR9809375A (pt) Sais de éster de 3-sulfato 5-alfa-pregn-16-3beta-ol-20-ona com atividade progestina
KR960030460U (ko) 성기 확장용 호형 평판 적층 링
MX9707759A (es) Sistesis de discurso en forma de ondas.
GB9611878D0 (en) Disposable sanitary underwear for women
AU6708298A (en) Benzoxepine derivatives which promote release of growth hormone

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
TC4A Change in name of a patent proprietor in a eurasian patent
MK4A Patent expired

Designated state(s): BY RU